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Abstract
Background: Hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDR) syndrome is an autosomal
dominant disorder. We report the first detailed case of hypoparathyroidism complicated by biliary atresia.
Case presentation: A 1-year-old Japanese girl was admitted to our hospital for living donor liver transplantation.
She suffered from obstructive jaundice owing to biliary atresia. She also had persistent hypocalcemia. Despite oral
calcium and abundant vitamin D supplementation, a laboratory test showed hypocalcemia (1.4 mmol/l) and
hyperphosphatemia (2.6 mmol/l). The intact parathyroid hormone level was normal (66 ng/l) with severe vitamin D
deficiency (25-hydroxy vitamin D: undetectable levels). There were no rachitic changes in metaphysis on X-rays. Her
family history showed that her mother had sensorineural deafness, a low serum calcium level (2.1 mmol/l), hypoplastic
left kidney, and a past history of an operation for right vesicoureteral reflux. We suspected that this patient and her
mother have hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome. A heterozygous GATA3 gene
mutation (c.736delGinsAT) was found in this patient and her mother, but not in her father.
Conclusion: This familial case confirms the importance of family history in the diagnosis of HDR syndrome. Regardless
of marked vitamin D deficiency, the complication of hypoparathyroidism prevented the onset of vitamin D deficiency
rickets in our patient.
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Background
The syndrome of hypoparathyroidism, sensorineural deaf-
ness, and renal dysplasia (HDR syndrome; OMIM: 146255)
is an autosomal dominant disease [1]. Hypoparathyroidism
causes symptomatic or asymptomatic hypocalcemia by
normal or inappropriately low levels of parathyroid
hormone (PTH) secretion [2]. Sensorineural deafness
usually occurs bilaterally and the degree of symptoms
varies from asymptomatic to severe hearing loss.
Severity of renal involvement also varies from no
renal abnormalities to renal dysplasia, hypoplasia,
cystic kidneys, and vesicoureteral reflux.
HDR syndrome is caused by haploinsufficiency of the
GATA3 gene on chromosome 10p15. GATA3 belongs to
GATA transcription factor families, which are involved
in vertebrate embryonic development of the parathyroid
glands, inner ears, kidney, thymus, and central nervous
system. GATA3 contains six exons, and encodes two
transactivating domains (TA1 and TA2) and two zinc
finger domains (ZnF1 and ZnF2) [3].
Vitamin D is a fat-soluble vitamin that is absorbed
from the intestines and requires bile acids for
solubilization. Vitamin D malabsorption is common in
jaundice patients with extra-hepatic biliary atresia (BA),
even after hepatoportoenterostomy [4]. Vitamin D
deficiency causes hypocalcemia, hypophosphatemia, and
subsequently causes rickets in BA patients.
Here we report the case of a girl with HDR syndrome
who presented with sustained severe vitamin D deficiency
associated with BA, but no rachitic changes were observed.
Case presentation
A 1-year-old Japanese girl was referred to our hospital
for living donor liver transplantation from her father.
She had the diagnosis of BA at the age of 2 months,
when she presented with hypocalcemia (1.4 mmol/l;
albumin-corrected calcium: 1.5 mmol/l; normal range:
2.0–2.8 mmol/l). She displayed no clinical signs of
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hypocalcemia, such as convulsion, muscle tremors,
lethargy, and irritability.
Even though hepatoportoenterostomy had been per-
formed 5 days after the diagnosis, progressive cholestasis
required liver transplantation. Persistent hypocalcemia,
which was considered to be associated with sustained
vitamin D deficiency, occurred (25-hydroxy vitamin D
[25OHD] was low [28.2 nmol/l, vitamin D deficiency is
defined as <50 nmol/l]) [5]. After the operation, she
was treated with oral calcium and vitamin D supple-
mentation (alfacalcidol). Alfacalcidol is the active form
of vitamin D3 and is used to treat vitamin D deficiency in
Japan because the native form of vitamin D is not available
for medical use. Despite the observation that serum
calcium levels were low and serum phosphate levels
remained at normal to high levels (1.8–3.1 mmol/l; nor-
mal range: 1.3–2.1 mmol/l), intact PTH levels were within
the normal range (19–66 ng/l; normal range: 10–72 ng/l).
At the first visit to our department, under conditions of
oral calcium and abundant alfacalcidol (3.0 μg/day), la-
boratory data showed marked hypocalcemia (1.4 mmol/l;
albumin-corrected calcium: 1.5 mmol/l), hyperphosphate-
mia (2.6 mmol/l), and a normal intact PTH level (66 ng/l)
with severe vitamin D deficiency (undetectable levels).
The urine calcium to creatinine ratio was 0.15 mmol/
mmol and tubular reabsorption of phosphate (%TRP)
was 99 %. Additionally, there were no skeletal abnor-
malities on a physical examination and on X-rays (Fig. 1).
These results suggested that she had hypoparathyroidism.
The patient’s height was 74.5 cm (-1.45 SD). Bone
mineral density of the lumbar spine (L1–L4) measured
by dual energy X-ray absorptiometry showed that the
bone mineral density Z-score was −1.0.
Her family history showed that her mother had
sensorineural deafness, hypoplastic left kidney, and a
past history of an operation for right vesicoureteral
reflux. Her mother’s serum calcium level was 2.1 mmol/l
(albumin-corrected calcium: 2.1 mmol/l; normal range:
2.2–2.5 mmol/l) and intact PTH level was 55 ng/l
(normal range: 10–65 ng/l). Further work-up by auditory
brainstem response testing and abdominal ultrasonog-
raphy showed that the patient had mild sensorineural
left deafness and bilateral renal cysts. Based on these
results, we strongly suspected that this patient and her
mother have HDR syndrome and we conducted GATA3
gene analysis.
Genomic DNA was extracted using a genomic DNA
Extraction Kit (Qiagen Inc., Tokyo, Japan). PCR primers
were designed to amplify all six exons and exon-intron
boundaries of the GATA3 gene. PCR products were
purified with the QIAquick Purification Kit (Qiagen
Inc.). Sequencing was performed with the BigDye
terminator v3.1 Cycle Sequencing Kit and the ABI Prism
310 Genetic Analyzer (Applied Biosystems, Foster City,
CA). The primer sequences for PCR are available upon
request. Sequence analysis showed a novel heterozygous
mutation in exon 3 of GATA3, c.736delGinsAT (Fig. 2),
causing a frameshift with a premature stop codon after a
new 57 amino acid sequence (p.G246Mfs57X) (Fig. 3).
No other mutation was detected in the cording region of
the GATA3 gene. The same mutation was identified in
her mother, but not in her father.
Before liver transplantation, 5 days of intravenous
multivitamin supplementation (including cholecalciferol
200 IU/day) raised calcium levels from 1.8 to 2.3 mmol/l.
After liver transplantation, cholestasis was resolved, but
hypocalcemia and hyperphosphatemia were not improved.
Therefore, oral calcium and alfacalcidol were required. At
present, serum calcium and phosphorus levels are within
the normal range by alfacalcidol (1.0 μg/day) alone.
Discussion
We report the case of a girl with hypocalcemia due to
BA. Further investigation showed HDR syndrome, which
was confirmed by molecular analysis.
Fig. 1 Radiographic image of the wrist and knee in the patient. No rachitic changes were observed in metaphysis
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BA and HDR syndrome are rare diseases. To the best
of our knowledge, only one patient who had BA and
HDR syndrome has been reported, although the details
were not described [6]. This is the first detailed report of
hypoparathyroidism complicated by biliary atresia.
Although there are only two cases, biliary atresia may be
phenotypic variation of HDR syndrome. Moreover, there
are a few reports about HDR syndrome with female
genital malformation, but pelvic ultrasound test was not
performed for the patient’s mother [7, 8].
The clinical characteristics of HDR syndrome are
known to be heterogeneous. In HDR patients, 62.3 %
exhibit the complete clinical triad, 28.6 % have hypo-
parathyroidism and renal disease, 2.6 % have deafness
and renal disease, and 6.5 % have isolated deafness [9].
Although our patient’s sensorineural deafness is unilat-
eral and is a mild abnormality, the triad was considered
to be fulfilled. The exact prevalence of HDR syndrome is
still unknown. There are likely to be some undiagnosed
cases of this disorder among sensorineural deafness pa-
tients, such as the patient’s mother. In fact, symptoms
present with varying degrees of severity, even in the
same family with an identical GATA3 mutation [9]. Be-
cause of this clinical heterogeneity, screening of GATA3
mutations is useful for diagnosis and genetic counseling.
In this study, we identified a novel mutation of GATA3
at exon 3 (c.736delGinsAT), causing a frameshift with a
premature stop codon (p.G246Mfs57X). To the best of
our knowledge, this mutation is novel and previously
unpublished. The role of ZnF2 is essential for DNA
binding, whereas the role of ZnF1 is stabilizing DNA
binding affinity and interaction with other zinc finger
proteins [3]. Ali et al. classified GATA3 mutations into
three classes as follows: class 1 is loss of DNA binding
potential as a result of lack ZnF2 and represents more
than 90 % of mutations reported in HDR syndrome;
class 2 is a reduction in DNA binding affinity due to the
mutation involving ZnF1; and class 3 is normal DNA
binding and affinity, but possibly involves a conform-
ational change [10]. In our case, the mutation resulted in
truncated protein lacking ZnF2 and can be classified as
class 1.
Rickets was reported to be found in 23 of 39
patients (59 %) with surgically unrepaired BA [11].
The pathogenesis of vitamin D deficiency rickets is as
follows [12]. Vitamin D deficiency decreases intestinal
calcium absorption. The resultant fall in circulating
ionized calcium levels stimulates PTH secretion,
which in turn causes an increase in renal phosphate ex-
cretion associated with an increase in mineral resorption
from bone. With progressively increasing PTH concentra-
tions, hypophosphatemia develops, which results in im-
pairment of apoptosis of hypertrophic chondrocytes at the
growth plate and mineralization of matrix vesicles in the
Fig. 2 Sequence analysis of the GATA3 gene. Electrochromatograms show that the patient and her mother had a heterozygous c.736delGinsAT
mutation. The patient’s healthy father did not have the mutation
Fig. 3 Schematic representation of the GATA3 gene. The GATA3 gene consists of six exons as indicated by boxes. Coding exons are shown in gray. The
GATA3 gene codes two transactivating domains (TA1 and TA2) and two zinc finger domains (ZnF1 and ZnF2). The coding region begins from exon 2
and the stop codon is located in exon 6. The arrow indicates the mutation site in our patient
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osteoid. Histological and radiological features of rickets
then develop. Collectively, excessive secretion of PTH and
a hypophosphatemic state are crucial for establishment of
vitamin D deficiency rickets [13].
Initially, researchers considered that hypocalcemia is
secondary to vitamin D deficiency due to cholestasis and
it can be treated by oral alfacalcidol and calcium supple-
mentation. However, finding of hypocalcemia with
hyperphosphatemia under a sustained severe vitamin D
deficient status contradicts this mechanism.
Conclusion
We identified a novel frameshift mutation of the GATA3
gene in a patient with HDR syndrome and BA. Regardless
of marked vitamin D deficiency, hypoparathyroidism
prevented the onset of vitamin D deficiency rickets.
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